Artificial intelligence diagnostics company Cardiologs today announced the results of a clinical study showing its AI-based ECG analysis software “significantly” reduces the rate of false-positive atrial fibrillation (AFib) detection in remote cardiac monitoring of certain patients.
The company, which has offices in Paris and Boston, worked with Valley Health System of northern New Jersey to track a cohort of 425 patients who each received a Medtronic Reveal LINQ implantable loop recorder (ILR) for known AFib or cryptogenic stroke.
Researchers evaluated 1,500 AF episodes and annotated each as either true or false, according to the study, published in the Journal of the American College of Cardiology Clinical Electrophysiology.
Get the full story on our sister site, Medical Design & Outsourcing.